REQUEST A DEMO
Total
USD $0.00
Search more companies

Komtur Pharmaceuticals Slovakia S.R.O. (Slovakia)

Main Activities: Administrative Management and General Management Consulting Services
Full name: Komtur Pharmaceuticals Slovakia S.R.O. Profile Updated: July 27, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Komtur Pharmaceuticals Slovakia S.R.O. is an enterprise in Slovakia, with the main office in Bratislava. It operates in the Administrative Management and General Management Consulting Services sector. The company was established on April 08, 2017. There was a net sales revenue increase of 28.06% reported in Komtur Pharmaceuticals Slovakia S.R.O.’s latest financial highlights for 2024. Its’ total assets recorded a growth of 165.16%. The net profit margin of Komtur Pharmaceuticals Slovakia S.R.O. increased by 4.55% in 2024.

Headquarters
Dolezalova, 3424/15C
Bratislava; Bratislavsky; Postal Code: 82104

Contact Details: Purchase the Komtur Pharmaceuticals Slovakia S.R.O. report to view the information.

Basic Information
Registered Capital:
Purchase the Komtur Pharmaceuticals Slovakia S.R.O. report to view the information.
Financial Auditors:
Purchase the Komtur Pharmaceuticals Slovakia S.R.O. report to view the information.
Incorporation Date:
April 08, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Attorney
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Komtur Pharmaceuticals Slovakia S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
28.06%
Total operating revenue
28.06%
Operating profit (EBIT)
19.41%
EBITDA
30.02%
Net Profit (Loss) for the Period
7.73%
Total assets
165.16%
Total equity
-19.8%
Operating Profit Margin (ROS)
4.95%
Net Profit Margin
4.55%
Return on Equity (ROE)
-4.93%
Debt to Equity Ratio
-10.54%
Quick Ratio
-0.26%
Cash Ratio
-0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?